Low Molecular Weight Heparin Decreases Pro-coagulant Activity in Clinical MSC Products January 18, 2024 Bioprinting, Bioprocessing, Blood, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering View this publication by clicking here.